Background Printed educational materials are widely used dissemination strategies to
improve the quality of healthcare professionals' practice and patient health outcomes …

Aims Guidelines recommend warfarin continuation rather than heparin bridging for
pacemaker and defibrillator surgery, after the BRUISE CONTROL trial demonstrated an 80 …

Objective Since 2010, several non–vitamin K antagonist oral anticoagulants (NOACs) have
been brought to the US market, yet little is known regarding their evolving adoption for …

Background Great efforts have been made to improve stroke prevention in atrial fibrillation
(AF) patients. Meanwhile, incidence of AF is increasing, which may affect the share of AF …

Objectives To present the 'Wise List'(a formulary of essential medicines for primary and
specialised care in Stockholm Healthcare Region) and assess adherence to the …

Background Four direct oral anticoagulants (DOACs) have been approved for clinical use by
many medicines regulatory agencies around the world. Due to increasing use of these drugs …

Background and Purpose—The purpose of this study was to investigate the impact of
improved antithrombotic treatment in atrial fibrillation after the introduction of non–vitamin K …

Purpose Since 2011, several direct oral anticoagulants (DOACs; dabigatran, rivaroxaban,
apixaban) have been introduced as alternatives to warfarin for stroke prophylaxis in atrial …

Background The “Coronavirus Disease 2019”(COVID-19) pandemic has become a major
challenge for all healthcare systems worldwide, and besides generating a high toll of …

Aims To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with
nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 …